A23D9/00

Process for making a bouillon tablet or bouillon cube

The invention relates to a manufacturing process for the production of a bouillon tablet or bouillon cube. In particularly the invention relates to a process for the production of a bouillon tablet or bouillon cube wherein the hygroscopic amorphous ingredients are encapsulated with fat and wherein the encapsulated hygroscopic amorphous ingredients have a fat content of between 22 to 80%.

PRODUCTION OF SHORT CHAIN FATTY ACIDS

The present invention relates to microbial cells comprising triacylglycerol (TAG) with short chain fatty acids (SCFA), as well as methods of using these cells to produce lipid comprising TAG with SCFAs.

SYNERGISTIC COMPOSITIONS
20230068175 · 2023-03-02 ·

The invention concerns novel compositions, comprising at least 2 different sources of ω-3 fatty acids, including wherein hoki roe at 5% (w/w) in powder or oil form and green-lipped mussel in powder or oil form. The compositions are particularly useful as/in supplements and/or animal or human food stuffs. The invention may further relate to the maintenance or treatment of human and veterinary conditions, such as use in the improvement of inflammation or joint related disorders that maybe associated with inflammation.

SYNERGISTIC COMPOSITIONS
20230068175 · 2023-03-02 ·

The invention concerns novel compositions, comprising at least 2 different sources of ω-3 fatty acids, including wherein hoki roe at 5% (w/w) in powder or oil form and green-lipped mussel in powder or oil form. The compositions are particularly useful as/in supplements and/or animal or human food stuffs. The invention may further relate to the maintenance or treatment of human and veterinary conditions, such as use in the improvement of inflammation or joint related disorders that maybe associated with inflammation.

MACROMOLECULAR CORROSION (MCIN) INHIBITORS: STRUCTURES, METHODS OF MAKING AND USING THE SAME
20230159841 · 2023-05-25 ·

Disclosed are multifunctional compounds represented by structural formula (I):

##STR00001##

methods of producing compounds represented by structural formula (I) and their use in inhibiting corrosion in corrodible material.

MACROMOLECULAR CORROSION (MCIN) INHIBITORS: STRUCTURES, METHODS OF MAKING AND USING THE SAME
20230159841 · 2023-05-25 ·

Disclosed are multifunctional compounds represented by structural formula (I):

##STR00001##

methods of producing compounds represented by structural formula (I) and their use in inhibiting corrosion in corrodible material.

PROCESS FOR ROASTING PLANT MATERIAL WITH OIL
20230157329 · 2023-05-25 ·

The present invention relates to a process for the production of a roasted plant material with oil. The oil used for roasting the plant material comprises the fatty acids C16:0 in the range of 1 to 25 wt% (based on weight of total fat) and C18:1 in the range of 60 to 90 wt% (based on weight of total fat) and C18:2 in the range of 0.1 to 20 wt% (based on weight of total fat).

HEMP SEED PRODUCTS AND METHODS AND SYSTEMS FOR PRODUCING SAME
20230157313 · 2023-05-25 ·

Methods and systems for producing improved hemp seed products, such as proteins and oils are provided.

METHOD TO FORMULATE AND PRODUCE VEGETABLE OIL BLENDS CONTAINING OPTIMALLY BALANCED FATTY ACIDS
20230157310 · 2023-05-25 ·

Modern diet has a very high omega 6 fatty acid content and a very high omega 6:omega 3 fatty acid ratio. The major sources of these in the modern diet are the vegetable oils consumed today. This imbalance of omega 6 and omega 3 fatty acids and the excessive amounts of omega 6 fatty acids in today's diet have been implicated in several chronic diseases. Thus, improving the balance of these fatty acids in the diet can have a positive nutritional and health impact. The present invention provides a method for formulating and producing vegetable oil blends, such that these vegetable oil blends will contain an optimal balance and optimal amounts of omega 6 and omega 3 fatty acids, along with optimal amounts of other oil nutrients, thus providing a vast improvement in the nutritional profile compared to the currently available vegetable oils.

NUTRACEUTICALS FOR THE MANAGEMENT OF CONDITIONS RELATED TO TYPE 2 DIABETES
20230115385 · 2023-04-13 ·

Disclosed are nutraceutical formulations, including extracts comprising the hydrophilic and lipophilic fractions of stabilized rice bran. Also disclosed are methods for using said nutraceutical formulations for the management or remediation of conditions related to type II diabetes in humans, including methods for decreasing HbA1c and fasting glucose blood concentrations, and for increasing serum fasting insulin levels.